Additional file 2: of TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice

Figure S1. cAT-MSCs have high expression of CD29, CD73, CD44, and CD90, and do not express CD31, CD34, or CD45. (TIFF 3502 kb

Additional file 1: of TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice

Supplementary materials. Canine adipose tissue-derived mesenchymal stem cells: isolation, culture, and characterization. (PDF 16 kb

Additional file 5: of TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice

Table S1. Primers used for this study. (PDF 33 kb

Additional file 4: of TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice

Figure S3. mRNA expression level of TSG-6 of naive cAT-MSCs, cAT-MSCs treated with transfection reagents only (cAT-MSC + transfection reagent), cAT-MSCs transfected with a scrambled siRNA (siCTL-cAT-MSC), or cAT-MSCs transfected with TSG-6 siRNA (siTSG6-cAT-MSC) was determined by real-time RT-PCR. Results are presented as the mean Âą standard deviation of three independent experiments. ***P < 0.001. (TIFF 1818 kb

Additional file 3: of TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice

Figure S2. cAT-MSCs have the ability to differentiate into adipocytes (Oil Red O staining), osteocytes (Alizarin Red S staining), and chondrocytes (Alcian Blue staining). Scale bars = 200 Îźm. (TIFF 9973 kb